Dose Escalation Methods in Phase I Cancer Clinical Trials

The guiding principle for dose escalation in phase I trials is to avoid unnecessary exposure of patients to subtherapeutic doses of an agent (ie, to treat as many patients as possible within the therapeutic dose range) while preserving safety and maintaining rapid accrual.

http://jnci.oxfordjournals.org/content/early/...jp079.full